GENEVA/LONDON (Reuters) - The use of an experimental drug on two U.S. charity workers with the deadly Ebola virus has prompted the World Health Organization (WHO) to consider the implications of making such treatments more widely available, it said on Wednesday.
The Geneva-based agency, which is hosting a two-day Emergency Committee of experts to decide on the international response to the disease that has killed nearly 1,000 people in West Africa, said it would convene a meeting of medical ethics experts early next week.
